Charlotte Elder - Academia.edu (original) (raw)
Uploads
Papers by Charlotte Elder
Journal of the Endocrine Society
Context The ACTH stimulation test (AST) is used to diagnose adrenal insufficiency, and often repe... more Context The ACTH stimulation test (AST) is used to diagnose adrenal insufficiency, and often repeated in patient’s when monitoring recovery of the hypothalamo-pituitary-adrenal axis. Objective To develop and validate a prediction model that uses previous AST results with new baseline cortisol to predict the result of a new AST. Design Retrospective, longitudinal cohort study in patients who had undergone at least two ASTs. Fractional polynomial regression with backwards variable selection. Setting Tertiary UK adult endocrinology centre. Patients Developed from 258 paired ASTs over 5 years in 175 adults (mean age 52.4 years, SD 16.4), validated on data from 111 patients over 1 year (51.8, 17.5) from the same centre collected after model development. Interventions Synacthen administered after baseline blood tests. Previous test baseline adrenocorticotropin hormone (ACTH) and cortisol alongside 30-minute cortisol, days between tests, and new baseline ACTH and cortisol used with calcula...
Clinical Endocrinology
ObjectiveWorldwide, adults and children are at risk of adrenal insufficiency largely due to infec... more ObjectiveWorldwide, adults and children are at risk of adrenal insufficiency largely due to infectious diseases and adrenal suppression from use of anti‐inflammatory glucocorticoids. Home waking salivary cortisone is an accurate screening test for adrenal insufficiency, it has potential to reduce costs, and patients prefer it to the adrenocorticotropin (ACTH) (synacthen) stimulation test. We carried out a service evaluation of home waking salivary cortisone in clinical care to identify implementation barriers.Design, Patients and MeasurementsService evaluation in a centre where 212 patients referred for adrenal insufficiency had a waking salivary cortisone. Problems encountered during testing were recorded and patient feedback, via focus groups, collected.ResultsFrom all patients providing a waking salivary cortisone 55% had a normal test, 23% adrenal suppression, and 22% an equivocal result requiring a clinical centre ACTH stimulation test. The median (interquartile range [IQR]) fo...
NEJM evidence, Jan 24, 2023
Archives of Disease in Childhood, Apr 12, 2023
Adrenal insufficiency (AI) is characterised by lack of cortisol production from the adrenal gland... more Adrenal insufficiency (AI) is characterised by lack of cortisol production from the adrenal glands. This can be a primary adrenal disorder or secondary to adrenocorticotropic hormone deficiency or suppression from exogenous glucocorticoids. Symptoms of AI in children may initially be non-specific and include growth faltering, lethargy, poor feeding, weight loss, abdominal pain, vomiting and lingering illnesses. AI is treated with replacement doses of hydrocortisone. At times of physiological stress such as illness, trauma or surgery, there is an increased requirement for exogenous glucocorticoids, which if untreated can lead to an adrenal crisis and death. There are no unified guidelines for those <18 years old in the UK, leading to substantial variation in the management of AI. This paper sets out guidance for intercurrent illness, medical, dental and surgical procedures to allow timely and appropriate recognition and treatment of AI and adrenal crisis for children and young people.
Diabetic Medicine, Aug 13, 2012
Endocrine Abstracts, May 2, 2023
Endocrine Abstracts, Oct 17, 2022
Paediatric and Perinatal Drug Therapy, 2005
Archives of Disease in Childhood-education and Practice Edition, Apr 8, 2021
This is a repository copy of Fifteen-minute consultation : the child with obesity.
Archives of Disease in Childhood-education and Practice Edition, Jan 19, 2023
Hormone Research in Paediatrics, 2008
Background/Aims: The effects of biosynthetic human growth hormone (r-hGH) in children with famili... more Background/Aims: The effects of biosynthetic human growth hormone (r-hGH) in children with familial short stature (FSS) are varied. We determined whether responsivity to r-hGH in FSS is dose-dependent. Method: Randomised trial of two doses (20 or 40 IU/m2 body surface area/week by daily subcutaneous injection) of r-hGH in 29 (24 male, 5 female) FSS children with assessment at adult height. Results: Age range at presentation was 5.1–10.5 years, height less than 1.5 standard deviation scores (SDS) below the mean, height velocity SDS greater than –1.5 and peak growth hormone response to provocative testing over 13.5 mU/l. Adult height data (SDS) at 16.5 ± 2.1 years for the low-dose group and 16.1 ± 1.1 years for the high-dose group (p = 0.62) were similar [low dose –1.06 (SD 0.75), high dose –1.02 (SD 0.83); p = 0.88]. The incremental effect of both doses on stature was minimal [low-dose difference in height actual-predicted 0.79 (SD 0.94), high dose 1.27 (SD 0.88); p = 0.12]. Conclusi...
55th ESPE Meeting, Aug 19, 2016
Journal of the Endocrine Society
Context The ACTH stimulation test (AST) is used to diagnose adrenal insufficiency, and often repe... more Context The ACTH stimulation test (AST) is used to diagnose adrenal insufficiency, and often repeated in patient’s when monitoring recovery of the hypothalamo-pituitary-adrenal axis. Objective To develop and validate a prediction model that uses previous AST results with new baseline cortisol to predict the result of a new AST. Design Retrospective, longitudinal cohort study in patients who had undergone at least two ASTs. Fractional polynomial regression with backwards variable selection. Setting Tertiary UK adult endocrinology centre. Patients Developed from 258 paired ASTs over 5 years in 175 adults (mean age 52.4 years, SD 16.4), validated on data from 111 patients over 1 year (51.8, 17.5) from the same centre collected after model development. Interventions Synacthen administered after baseline blood tests. Previous test baseline adrenocorticotropin hormone (ACTH) and cortisol alongside 30-minute cortisol, days between tests, and new baseline ACTH and cortisol used with calcula...
Clinical Endocrinology
ObjectiveWorldwide, adults and children are at risk of adrenal insufficiency largely due to infec... more ObjectiveWorldwide, adults and children are at risk of adrenal insufficiency largely due to infectious diseases and adrenal suppression from use of anti‐inflammatory glucocorticoids. Home waking salivary cortisone is an accurate screening test for adrenal insufficiency, it has potential to reduce costs, and patients prefer it to the adrenocorticotropin (ACTH) (synacthen) stimulation test. We carried out a service evaluation of home waking salivary cortisone in clinical care to identify implementation barriers.Design, Patients and MeasurementsService evaluation in a centre where 212 patients referred for adrenal insufficiency had a waking salivary cortisone. Problems encountered during testing were recorded and patient feedback, via focus groups, collected.ResultsFrom all patients providing a waking salivary cortisone 55% had a normal test, 23% adrenal suppression, and 22% an equivocal result requiring a clinical centre ACTH stimulation test. The median (interquartile range [IQR]) fo...
NEJM evidence, Jan 24, 2023
Archives of Disease in Childhood, Apr 12, 2023
Adrenal insufficiency (AI) is characterised by lack of cortisol production from the adrenal gland... more Adrenal insufficiency (AI) is characterised by lack of cortisol production from the adrenal glands. This can be a primary adrenal disorder or secondary to adrenocorticotropic hormone deficiency or suppression from exogenous glucocorticoids. Symptoms of AI in children may initially be non-specific and include growth faltering, lethargy, poor feeding, weight loss, abdominal pain, vomiting and lingering illnesses. AI is treated with replacement doses of hydrocortisone. At times of physiological stress such as illness, trauma or surgery, there is an increased requirement for exogenous glucocorticoids, which if untreated can lead to an adrenal crisis and death. There are no unified guidelines for those <18 years old in the UK, leading to substantial variation in the management of AI. This paper sets out guidance for intercurrent illness, medical, dental and surgical procedures to allow timely and appropriate recognition and treatment of AI and adrenal crisis for children and young people.
Diabetic Medicine, Aug 13, 2012
Endocrine Abstracts, May 2, 2023
Endocrine Abstracts, Oct 17, 2022
Paediatric and Perinatal Drug Therapy, 2005
Archives of Disease in Childhood-education and Practice Edition, Apr 8, 2021
This is a repository copy of Fifteen-minute consultation : the child with obesity.
Archives of Disease in Childhood-education and Practice Edition, Jan 19, 2023
Hormone Research in Paediatrics, 2008
Background/Aims: The effects of biosynthetic human growth hormone (r-hGH) in children with famili... more Background/Aims: The effects of biosynthetic human growth hormone (r-hGH) in children with familial short stature (FSS) are varied. We determined whether responsivity to r-hGH in FSS is dose-dependent. Method: Randomised trial of two doses (20 or 40 IU/m2 body surface area/week by daily subcutaneous injection) of r-hGH in 29 (24 male, 5 female) FSS children with assessment at adult height. Results: Age range at presentation was 5.1–10.5 years, height less than 1.5 standard deviation scores (SDS) below the mean, height velocity SDS greater than –1.5 and peak growth hormone response to provocative testing over 13.5 mU/l. Adult height data (SDS) at 16.5 ± 2.1 years for the low-dose group and 16.1 ± 1.1 years for the high-dose group (p = 0.62) were similar [low dose –1.06 (SD 0.75), high dose –1.02 (SD 0.83); p = 0.88]. The incremental effect of both doses on stature was minimal [low-dose difference in height actual-predicted 0.79 (SD 0.94), high dose 1.27 (SD 0.88); p = 0.12]. Conclusi...
55th ESPE Meeting, Aug 19, 2016